MichaelFranzPrestiMDPhD
Neurology • Gainesville, FLPain Medicine, Sleep Medicine
CEO, SafeRX Pharmaceuticals Inc.
Dr. Presti is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1600 SW Archer Rd
Gainesville, FL 32610Phone+1 352-273-8737Fax+1 352-273-9154
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Sleep Medicine, 2012 - 2013- Mayo Clinic College of Medicine and Science (Rochester)Residency, Neurology, 2009 - 2012
University of Maryland Medical Center Midtown CampusInternship, Transitional Year, 2008 - 2009
University of Florida College of MedicineClass of 2008
Certifications & Licensure
FL State Medical License 2022 - 2026
MA State Medical License 2022 - 2024
CA State Medical License 2019 - 2023
NY State Medical License 2021 - 2023
OR State Medical License 2014 - 2021
MN State Medical License 2009 - 2014- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Sleep Medicine
Publications & Presentations
PubMed
- 53 citationsStriatal opioid peptide content in an animal model of spontaneous stereotypic behavior.Michael F. Presti, Mark H. Lewis
Behavioural Brain Research. 2005-02-28 - 23 citationsDegeneration of Brainstem Respiratory Neurons in Dementia with Lewy BodiesMichael F. Presti, Ann M. Schmeichel, Phillip A. Low, Joseph E. Parisi, Eduardo E. Benarroch
Sleep. 2014-02-01 - 25 citationsMeasurements of RF heating during 3.0-T MRI of a pig implanted with deep brain stimulator.Krzysztof R. Gorny, Michael F. Presti, Stephan J. Goerss, Sun C. Hwang, Dong Pyo Jang
Magnetic Resonance Imaging. 2013-06-01
Journal Articles
- Degeneration of brainstem respiratory neurons in dementia with Lewy bodiesPresti MF; Schmeichel MA; Low PA; Parisi JE; Benarroch EE, Sleep, 2/2014
Authored Content
- Fix Roof, Not Tarp in Battle Against Opioid CrisisMay 2021
Press Mentions
SafeRX Pharmaceuticals to Exhibit Alcohol-Resistant Opioid Platform at 2021 FSIPP/FSPMR Annual ConferenceJuly 26th, 2021
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
